在脏分配系统中,目前的零HLAABDR-不匹配优先级是否应该继续? :一个批判性的评价
Douglas Keith1, Elizabeth Lessmann
1Ascension Sacred Heart Kidney Transplant Program Pensacola, Florida.
Kidney360
|January 13, 2026
概括
分配系统 (KAS) 零人类白细胞抗原 (HLA) ABDR-不匹配优先级提供最小的器官效用益. 这一政策不公平地不利于种族少数群体,应该从移植分配中删除.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 移植免疫学 移植免疫学
- 公共卫生政策 公共卫生政策
背景情况:
- 分配系统 (KAS) 优先考虑零的人类白细胞抗原 (HLA) ABDR-不匹配候选人.
- 这个优先级可能会使O型血型候选人处于劣势,因为脏转移.
- 这项研究调查了接受者,供体转移和与零HLAABDR不匹配移植相关的结果.
研究的目的:
- 为了识别零HLA ABDR-不匹配脏的接受者.
- 量化捐赠者转移到非相同的ABO接受者.
- 评估对移植前透析和移植后结果的影响.
主要方法:
- 从2014年12月4日开始对成年已故捐赠者移植的分析.
- 不包括多器官,高CPRA,再移植,儿科和紧急病例.
- 定义零不匹配的接受者是那些<98%的CPRA接受零HLAABDR不匹配脏的人.
主要成果:
- 零HLAABDR不匹配的接受者主要是白人,女性,CPRA较低,透析时间较短.
- 2.46%的O型献血者被转移到非O型接受者.
- 零HLA ABDR不匹配提供了一个小的移植生存优势,但没有患者生存的好处.
结论:
- 零HLA ABDR-不匹配优先级不成比例地影响种族少数群体.
- 它导致显著的O型血液供体转移,而器官效用改善最小.
- 建议将此优先级从脏分配中删除.
相关概念视频
01:28Kidney Transplant I: Introduction
339
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
339
01:26Kidney Transplant II: Surgical Procedure
303
Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
303
01:24Tissue Transplantation
894
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
894
01:22Bone Marrow Sampling and Transplants
876
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
876
01:16Kidney Transplant III: Nursing Management
312
Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
312